Clinical Lymphoma Myeloma & Leukemia
Latest Publications

TOTAL DOCUMENTS

7205

(FIVE YEARS 2159)

H-INDEX

(FIVE YEARS 5)

Published By Elsevier

2152-2669, 2152-2650

Latest Documents Most Cited Documents Contributed Authors Related Sources Related Keywords

Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS)

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2022.01.002 ◽

2022 ◽

Author(s):

Onyee Chan ◽

Najla Al Ali ◽

David Sallman ◽

Eric Padron ◽

Jeffrey Lancet ◽

...

Keyword(s):

Myelodysplastic Syndromes ◽

Gene Mutations ◽

Prognostic Impact ◽

Therapeutic Outcomes

Download Full-text

Erratum to ‘Potential New Therapeutic Approaches for Myelofibrosis’ [Clinical Lymphoma Myeloma & Leukemia 21S1 (2021) S130-S133 / EXABS-189-MPN]

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2021.12.001 ◽

2022 ◽

Keyword(s):

Therapeutic Approaches ◽

New Therapeutic Approaches

Download Full-text

Salvage high-dose melphalan with autologous stem cell transplantation as bridge to consolidation therapy for chemoresistant aggressive B-cell lymphoma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2022.01.007 ◽

2022 ◽

Author(s):

Dominic Kaddu-Mulindwa ◽

Philipp Gödel ◽

Nadine Kutsch ◽

Jan-Michel Heger ◽

Christof Scheid ◽

...

Keyword(s):

Stem Cell ◽

Stem Cell Transplantation ◽

B Cell ◽

Autologous Stem Cell Transplantation ◽

Cell Lymphoma ◽

B Cell Lymphoma ◽

High Dose ◽

Consolidation Therapy ◽

High Dose Melphalan ◽

Aggressive B Cell Lymphoma

Download Full-text

Managing Relapsed Mantle Cell Lymphoma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2022.01.008 ◽

2022 ◽

Author(s):

Jason T. Romancik ◽

Drew Gerber ◽

Tony Zhuang ◽

Jonathon B. Cohen

Keyword(s):

Mantle Cell Lymphoma ◽

Cell Lymphoma ◽

Mantle Cell

Download Full-text

Clinical Characteristics and Survival Outcomes of Primary Effusion Lymphoma: A National Cancer Database Study

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2022.01.006 ◽

2022 ◽

Author(s):

Firas Baidoun ◽

Muhamad Alhaj Moustafa ◽

Han W. Tun ◽

Brian T. Hill

Keyword(s):

Clinical Characteristics ◽

Primary Effusion Lymphoma ◽

Survival Outcomes ◽

National Cancer Database ◽

Database Study

Download Full-text

Impact of insurance on overall survival in acute lymphoblastic leukemia: A SEER database study

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2022.01.001 ◽

2022 ◽

Author(s):

Utsav Joshi ◽

Shital Khanal ◽

Uttam Bhetuwal ◽

Adheesh Bhattarai ◽

Prajwal Dhakal ◽

...

Keyword(s):

Overall Survival ◽

Acute Lymphoblastic Leukemia ◽

Lymphoblastic Leukemia ◽

Seer Database ◽

Database Study

Download Full-text

The Effect of Fedratinib, a Selective Inhibitor of Janus Kinase 2, on Weight and Metabolic Parameters in Patients with Intermediate- or High-risk Myelofibrosis

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2022.01.003 ◽

2022 ◽

Author(s):

Douglas Tremblay ◽

Lara Cavalli ◽

Oumar Sy ◽

Shelonitda Rose ◽

John Mascarenhas

Keyword(s):

High Risk ◽

Selective Inhibitor ◽

Janus Kinase ◽

Metabolic Parameters ◽

Janus Kinase 2

Download Full-text

Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2022.01.005 ◽

2022 ◽

Author(s):

Meletios-Athanasios Dimopoulos ◽

Paul Richardson ◽

Sagar Lonial

Keyword(s):

Multiple Myeloma ◽

Treatment Options ◽

Refractory Multiple Myeloma ◽

Heavily Pretreated

Download Full-text

Granulomatous Myositis as a Manifestation of Chronic Graft-Versus-Host Disease: A Case Series and Review of the Literature

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2022.01.004 ◽

2022 ◽

Author(s):

Claudie Roy ◽

Emily J Lai ◽

Abigail Hyun Ae Lee ◽

Peter Schutz ◽

John Maguire ◽

...

Keyword(s):

Graft Versus Host Disease ◽

Case Series ◽

Review Of The Literature ◽

Host Disease ◽

Graft Versus Host ◽

Granulomatous Myositis

Download Full-text

Mini-Hyper-CVD Combinations for Older Adults: Results of Recent Trials and a Glimpse into the Future

Clinical Lymphoma Myeloma & Leukemia ◽

10.1016/j.clml.2021.12.005 ◽

2021 ◽

Author(s):

Marlise R. Luskin

Keyword(s):

Older Adults ◽

The Future

Download Full-text

Clinical Lymphoma Myeloma & LeukemiaLatest Publications

TOTAL DOCUMENTS

H-INDEX

Published By Elsevier

Therapeutic Outcomes and Prognostic Impact of Gene Mutations Including TP53 and SF3B1 in Patients with Del(5q) Myelodysplastic Syndromes (MDS)

Erratum to ‘Potential New Therapeutic Approaches for Myelofibrosis’ [Clinical Lymphoma Myeloma & Leukemia 21S1 (2021) S130-S133 / EXABS-189-MPN]

Salvage high-dose melphalan with autologous stem cell transplantation as bridge to consolidation therapy for chemoresistant aggressive B-cell lymphoma

Managing Relapsed Mantle Cell Lymphoma

Clinical Characteristics and Survival Outcomes of Primary Effusion Lymphoma: A National Cancer Database Study

Impact of insurance on overall survival in acute lymphoblastic leukemia: A SEER database study

The Effect of Fedratinib, a Selective Inhibitor of Janus Kinase 2, on Weight and Metabolic Parameters in Patients with Intermediate- or High-risk Myelofibrosis

Treatment Options for Patients With Heavily Pretreated Relapsed and Refractory Multiple Myeloma

Granulomatous Myositis as a Manifestation of Chronic Graft-Versus-Host Disease: A Case Series and Review of the Literature

Mini-Hyper-CVD Combinations for Older Adults: Results of Recent Trials and a Glimpse into the Future

Clinical Lymphoma Myeloma & Leukemia
Latest Publications